{
    "clinical_study": {
        "@rank": "33476", 
        "arm_group": [
            {
                "arm_group_label": "TMS Intervention - TBS followed by High Frequency", 
                "arm_group_type": "Experimental", 
                "description": "Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days in the order of Theta Burst Stimulation followed by High frequency stimulation"
            }, 
            {
                "arm_group_label": "TMS Intervention - High frequency stimulation followed by TBS", 
                "arm_group_type": "Experimental", 
                "description": "Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days in the order of High Frequency stimulation followed by Theta Burst Stimulation"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this pilot study is to test whether Transcranial Magnetic Stimulation (TMS)\n      may alleviate the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will\n      test various methods of TMS in a small pilot study to investigate what methods may have\n      clinical potential. This is a small pilot study to determine feasibility and signal to\n      potentially inform future trials."
        }, 
        "brief_title": "TMS for CRPS - Pilot Study", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Complex Regional Pain Syndrome (CRPS)", 
        "condition_browse": {
            "mesh_term": "Complex Regional Pain Syndromes"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age 18 or older\n\n          2. Diagnosis of CRPS (complex regional pain syndrome)\n\n          3. Average pain level reported on Numerical Rating Scale meets entry criteria\n\n          4. Ability to perform the experimental task and procedures.\n\n        Exclusion Criteria:\n\n          1. MRI contraindication (metal implants or devices, claustrophobia)\n\n          2. TMS Contraindication (eg metal implant or devices near the site of stimulation)\n\n          3. History of epilepsy\n\n          4. History of a psychological or psychiatric disorder that would interfere with study\n             procedures, at the discretion of the researcher.\n\n          5. Neurologic illness that would interfere with brain integrity\n\n          6. Current medical condition or medication use that would interfere with study\n             procedures or data integrity, at the discretion of the researcher.\n\n          7. Currently pregnant or planning to become pregnant.\n\n          8. On going legal action or disability claim."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "4", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926119", 
            "org_study_id": "25894"
        }, 
        "intervention": {
            "arm_group_label": [
                "TMS Intervention - TBS followed by High Frequency", 
                "TMS Intervention - High frequency stimulation followed by TBS"
            ], 
            "intervention_name": "Transcranial Magnetic Stimulation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Palo Alto", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94304"
                }, 
                "name": "Stanford University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in pain", 
            "safety_issue": "No", 
            "time_frame": "End of each of the 5 treatment sessions and at 1-week follow-up compared to baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926119"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Stanford University", 
            "investigator_full_name": "Sean Mackey", 
            "investigator_title": "Chief, Division of Pain Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "As assessed by functional capacity exam and physical exam", 
                "measure": "Change in motor function and coordination", 
                "safety_issue": "No", 
                "time_frame": "End of 5-day treatment series and at 1-week follow-up relative to baseline"
            }, 
            {
                "measure": "Change in sensory perception", 
                "safety_issue": "No", 
                "time_frame": "End of each treatment session and at 1-week follow-up as compared to baseline"
            }, 
            {
                "measure": "Change in vasomotor function", 
                "safety_issue": "No", 
                "time_frame": "End of each treatment session and at 1-week follow-up as compared to baseline"
            }, 
            {
                "measure": "Change in sudomotor function", 
                "safety_issue": "No", 
                "time_frame": "End of each treatment session and at 1-week follow-up as compared to baseline"
            }, 
            {
                "measure": "Trophic changes", 
                "safety_issue": "No", 
                "time_frame": "End of each treatment session and at 1-week follow-up as compared to baseline"
            }, 
            {
                "measure": "Change in motor strength and joint range of motion", 
                "safety_issue": "No", 
                "time_frame": "End of each of the 5 treatment sessions and at 1-week follow-up relative to baseline"
            }
        ], 
        "source": "Stanford University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}